ArticleGlobal spine journal2026
Recommendations of the International Consensus Meeting (ICM) 2025 on Spinal Infections: Part A Pyogenic Spondylodiscitis.
Article in Global spine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Study DesignSystematic review with guidelines.ObjectiveTo develop evidence-based, globally applicable recommendations for diagnosis and management of pyogenic spondylodiscitis (PSI) as a part of the International Consensus Meeting (ICM) 2025 on Spinal Infection.MethodsA multi-phase consensus process combined systematic evidence appraisal (PubMed, Scopus, Web of Science, Clinicaltrials.org) with structured expert deliberation. Seven domains were explored: diagnosis, microbiological workup, antibiotic management, response assessment, morphology-based planning, surgical techniques, and adjunctive measures.ResultsExpert consensus established that serum albumin (<3.5 g/dL) is a critical prognostic marker, while ESR and CRP remain the most reliable diagnostic tests. The assembly strongly rejected initiating empirical treatment without tissue diagnosis, even in early-stage infection. Surgical fixation is recommended for instability, deformity, or neurological deficit, with instrumentation levels tailored to bone destruction and patient-specific factors like osteoporosis. While MRI is the gold standard for initial diagnosis, its role in monitoring is limited, as radiological progression in clinically stable patients does not necessitate surgery. Advanced adjuncts, including Next-Generation Sequencing (NGS) and Vacuum-Assisted Closure (VAC), show promise in enhancing pathogen detection and wound healing, respectively.ConclusionEffective PSI management requires integrating clinical, laboratory, and morphological data. Meticulous debridement and targeted antimicrobial therapy remain the cornerstones of treatment. This consensus provides a practical guide for clinicians while highlighting the need for prospective, multicenter research to validate emerging technologies and standardize global surgical protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.